Nuvalent Stock (NASDAQ:NUVL), Quotes and News Summary

Q: What sector and industry does Nuvalent (NUVL) operate in?

Nuvalent is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Nuvalent Stock (NASDAQ: NUVL) stock price, news, charts, stock research, profile.

Open	$62.950
Close	$62.760
Volume / Avg.	1.246M / 455.857K
Day Range	61.795 - 64.710
52 Wk Range	29.250 - 89.390
Market Cap	$4.021B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	27
Short Interest	32.73%
Days to Cover	18.41

Recent News

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet

Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance to uncover new information.

Chris Katje

Challenging Road Ahead for Cancer Drugs, Nuvalent Seeks to Break the Mold

Stifel initiated coverage on Nuvalent Inc (NASDAQ: NUVL), recognizing that adopting a bullish stance in anticipation of Phase 1 cancer drug data, mainly when derived from heavily pretreated patients, has proven unprofitable for approximately two years.

Vandana Singh

Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Nuvalent Inc

Sector

Health Care

Industry

Biotechnology

Nuvalent Inc is a clinical stage biopharmaceutical company focused on creating precisely targeted th...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Nuvalent (NUVL) stock?

You can purchase shares of Nuvalent (NASDAQ: NUVL) through any online brokerage.

View our list of the best stock brokerages.

Who are Nuvalent's (NUVL) competitors?

Other companies in Nuvalent’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS), Alkermes (NASDAQ:ALKS) and SpringWorks Therapeutics (NASDAQ:SWTX).

What is the target price for Nuvalent (NUVL) stock?

The latest price target for Nuvalent (NASDAQ: NUVL) was reported by Jefferies on Wednesday, April 17, 2024. The analyst firm set a price target for 97.00 expecting NUVL to rise to within 12 months (a possible 54.56% upside). 15 analyst firms have reported ratings in the last year.

Current Stock Price for Nuvalent (NUVL)?

The stock price for Nuvalent (NASDAQ: NUVL) is $62.76 last updated Today at April 19, 2024 at 4:00 PM EDT.

Does Nuvalent (NUVL) pay a dividend?

There are no upcoming dividends for Nuvalent.

When is Nuvalent (NASDAQ:NUVL) reporting earnings?

Nuvalent’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Is Nuvalent (NUVL) going to split?

There is no upcoming split for Nuvalent.

What sector and industry does Nuvalent (NUVL) operate in?

Nuvalent is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-